Fifth Third Bancorp’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-1,345
Closed -$55K 3134
2015
Q2
$55K Sell
1,345
-2,567
-66% -$92K ﹤0.01% 1410
2015
Q1
$138K Sell
3,912
-276
-7% -$9.34K ﹤0.01% 1087
2014
Q4
$135K Buy
4,188
+119
+3% +$3.44K ﹤0.01% 1068
2014
Q3
$114K Sell
4,069
-603
-13% -$18.4K ﹤0.01% 1129
2014
Q2
$141K Sell
4,672
-14,467
-76% -$399K ﹤0.01% 1065
2014
Q1
$530K Sell
19,139
-18,498
-49% -$484K 0.01% 702
2013
Q4
$961K Sell
37,637
-868
-2% -$26.8K 0.01% 604
2013
Q3
$1.15M Buy
38,505
+14,053
+57% +$391K 0.01% 554
2013
Q2
$703K Buy
+24,452
New +$674K 0.01% 657

Other funds holding BRLI

Fifth Third Bancorp's BRLI Position: Q3 2015 in Review

Fifth Third Bancorp sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 1,345 shares — an estimated $55K sold.

Fifth Third Bancorp first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $1.15M in Q3 2013. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Fifth Third Bancorp reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Fifth Third Bancorp sold 1,345 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $55K.
  • Fifth Third Bancorp first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Fifth Third Bancorp's BIO-REFERENCE LABS INC-NEW- position peaked at $1.15M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Fifth Third Bancorp's 13F filing for Q3 2015, filed 13 Nov 2015.